immunosuppressive

It has been in use since 1983 and is one of the most widely used immunosuppressive drugs.

The immunosuppressive regimen is begun just before or after surgery.

In order to prevent it, patients must take a regimen of immunosuppressive drugs.

For a list of immunosuppressive drugs, see the transplant rejection page.

Thus, recipients do not need to take immunosuppressive drugs.

Patients on immunosuppressive medications have a 10- to 100-fold increased risk of cancer compared to the general population.

Immunosuppressive drugs are used to suppress the immune response, but the effect is not specific.

They could interact with medicines such as antibiotics or immunosuppressive drugs.

Most of the time, acute rejection can be treated with immunosuppressive medicines.

Because many immunosuppressive medications are toxic, this was not a surprising finding.

However, in essence, all immunosuppressive drugs have the potential to cause immunodeficiency.

Response to corticosteroid treatment and immunosuppressive agents also support this idea.

Immunosuppressive drugs prevent the immune system from controlling the virus.

Therefore all immunosuppressive factors can play a part.

Our operative and immunosuppressive approach has been described elsewhere.

Immunosuppressive agents are continued in the intensive care unit.

Corticosteroids and other immunosuppressive drugs are the mainstay of treatment.

In some cases, the disease only appears when the domestic animal develops an immunosuppressive condition.

Immunosuppressive therapy has been effective in halting the disease for laboratory animals.

Unresponsive patients may be tried on other immunosuppressive medications.

Acute rejection is the most common and the primary target of immunosuppressive agents.

Immunosuppressive drugs, which weaken your body's ability to fight infections, must be taken indefinitely.

A history of topical steroid or immunosuppressive agent is noted.

This is supported by excellent response to immunosuppressive (steroid) therapy.